Back to UBS Group AG UBS Group AG

ARQTARQT
26 quarters

Position history for UBS Group AGUBS Group AG's holdings in ARCUTIS BIOTHERAPEUTICS INC

UBS Group AG holds 3.3M shares of ARQT (ARCUTIS BIOTHERAPEUTICS INC), worth $87.4M as of 2026-Q2. The position was increased (+0.1% shares). ARQT represents 0.0% of UBS Group AG's portfolio.

Current Value

$87.4M

Current Shares

3.3M

Total Value Change

+$87.2M

Total Shares Change

+3.3M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
3.3M
+0.1%
$87.4M0.0%$26.22
30
2026-Q1
Increased
3.3M
+2.6%
$78.4M0.0%$23.56
30
2025-Q4
Increased
3.2M
+10.0%
$94.2M0.0%$29.04
33
2025-Q3
Increased
2.9M
+0.4%
$55.6M0.0%$18.85
29
2025-Q2
Increased
2.9M
+0.6%
$41.2M0.0%$14.02
29
2025-Q1
Increased
2.9M
+4.7%
$45.7M0.0%$15.64
31
2024-Q4
Increased
2.8M
+1166.8%
$38.9M0.0%$13.93
47
2024-Q3
Decreased
220,194
-28.9%
$2M0.0%$9.30
0
2024-Q2
Decreased
309,571
-36.9%
$2.9M0.0%$9.30
0
2024-Q1
Increased
490,677
+233x
$4.9M0.0%$9.91
43
2023-Q4
Decreased
2,100
-96.7%
$6,7830.0%$3.23
0
2023-Q3
Decreased
64,142
-54.1%
$340,5940.0%$5.31
0
2023-Q2
Increased
139,752
+57.4%
$1.3M0.0%$9.53
36
2023-Q1
Decreased
88,779
-54.1%
$976,5690.0%$11.00
0
2022-Q4
Increased
193,311
+720.1%
$2.9M0.0%$14.80
42
2022-Q3
Increased
23,572
+41.0%
$450,0000.0%$19.11
32
2022-Q2
Decreased
16,719
-69.2%
$357,0000.0%$21.31
0
2022-Q1
Decreased
54,302
-0.7%
$1M0.0%$19.26
0
2021-Q4
Increased
54,663
+81.3%
$1.1M0.0%$20.74
39
2021-Q3
Increased
30,155
+167.1%
$720,0000.0%$23.89
40
2021-Q2
Decreased
11,290
-44.8%
$309,0000.0%$27.29
0
2021-Q1
New
20,446
-
$591,0000.0%$28.93
34
2020-Q4
Exited
0
-100.0%
$00.0%$28.13
0
2020-Q3
Decreased
613
-80.3%
$18,0000.0%$29.30
0
2020-Q2
Decreased
3,110
-51.9%
$94,0000.0%$30.24
0
2020-Q1
New
6,468
-
$193,0000.0%$29.80
32

Other major holders of ARQT: BlackRock, Inc., JENNISON ASSOCIATES LLC, VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used